Top 10 Companies in the Global Intravenous Injection Aseptic Packaging Market (2026): Market Leaders Driving Global Healthcare

MARKET INSIGHTS

Global Intravenous Injection Aseptic Packaging market size was valued at USD 8.72 billion in 2024. The market is projected to grow from USD 9.45 billion in 2025 to USD 16.28 billion by 2032, underpinned by a CAGR of 7.1 % during the forecast period.

Intravenous injection aseptic packaging refers to specialized sterile containment systems designed to maintain pharmaceutical products’ integrity during storage and administration. These solutions include vials, IV bags, and pre‑filled syringes manufactured under stringent aseptic conditions to prevent microbial contamination. The packaging employs materials such as glass, plastics, and elastomers that meet pharmacopeial standards for parenteral drug delivery.

Market growth is underpinned by rising demand for biologics and injectable therapies, with the global biologics market projected to reach USD 719 billion by 2030. Rising hospital‑acquired infections—affecting 7 % of patients in developed nations—have accelerated the adoption of advanced aseptic technologies. Regulatory pressures, particularly FDA’s 2023 guidance on container‑closure systems, are steering manufacturers toward innovative solutions like ready‑to‑use packaging formats that reduce contamination risks during clinical handling.

Global Intravenous Injection Aseptic Packaging Market – View in Detailed Research Report

1. Amcor

   Headquarters: Australia

   Key Offering: Flexible polymer aseptic packaging, sterile medical films, and over‑wrap solutions.

   Amcor’s portfolio of high‑barrier polymer films positions it as the benchmark for biologic and vaccine packaging. The company’s global manufacturing network spans more than 30 countries, enabling rapid response to regional demand and regulatory requirements. Amcor’s focus on recyclable film technology aligns with the pharmaceutical industry’s shift toward circular packaging solutions.

   Sustainability & Growth Initiatives:

   • Global manufacturing footprint with 30+ sites
   • Leader in high‑barrier polymer films
   • Partnerships with major biopharma clients
   • Commitment to carbon‑neutral operations by 2025

2. Gerresheimer

   Headquarters: Germany

   Key Offering: Glass vials and blow‑and‑blind technology for biologics.

   Gerresheimer’s glass expertise delivers containers that meet the stringent sterility and integrity requirements of advanced biologics. The company’s robust R&D pipeline focuses on glass chemistry innovations that reduce manufacturing energy consumption while maintaining product performance.

   Sustainability & Growth Initiatives:

   • Dominant glass vial market share
   • Advanced blow‑and‑blind technology
   • Strong presence in EU and US markets
   • Investment in circular glass sourcing

3. SCHOTT

   Headquarters: Germany

   Key Offering: High‑quality glass containers and sterile packaging solutions.

   SCHOTT supplies glass vials that offer superior barrier properties for biologics, gene therapies, and specialty drugs. The company’s commitment to renewable energy and waste reduction underscores its leadership in sustainable glass manufacturing.

   Sustainability & Growth Initiatives:

   • Leading glass vial provider
   • Integrated sterile packaging solutions
   • Strong R&D in glass chemistry
   • Renewable energy usage >50 % of operations

4. Becton Dickinson

   Headquarters: United States

   Key Offering: Sterilization bags, secondary packaging, and aseptic filling lines.

   Becton Dickinson’s comprehensive aseptic technology portfolio supports hospitals and manufacturers worldwide. The company’s focus on eco‑friendly sterilization processes and waste reduction aligns with global sustainability goals.

   Sustainability & Growth Initiatives:

   • Global leader in aseptic technology
   • Comprehensive secondary packaging portfolio
   • Collaboration with major hospitals
   • Reduced single‑use plastic footprint

5. WestRock

   Headquarters: United States

   Key Offering: Sterilization bags and advanced secondary packaging.

   WestRock’s innovative bag designs deliver high‑barrier protection while integrating seamlessly into supply chains. The company’s sustainability agenda targets zero‑waste packaging by 2030.

   Sustainability & Growth Initiatives:

   • Advanced bag technologies
   • High‑barrier sterilization bags
   • Strong supply chain integration
   • 2030 zero‑waste packaging goal

6. Syntegon Technology

   Headquarters: Germany

   Key Offering: Turnkey aseptic filling lines and automation.

   Syntegon enables smaller biotech firms to outsource production while maintaining strict sterility. The company’s energy‑efficient line designs reduce operational footprints.

   Sustainability & Growth Initiatives:

   • Turnkey aseptic solutions
   • High automation & precision
   • Support for small biotech
   • Energy‑efficient line design

7. Catalent

   Headquarters: United States

   Key Offering: Pre‑filled syringes for oncology and specialty drugs.

   Catalent’s pre‑filled syringe platform delivers sterility assurance for oncology therapies. The company’s scalable production capacity supports rapid market entry.

   Sustainability & Growth Initiatives:

   • Pre‑filled syringe expertise
   • Oncology drug focus
   • Integrated sterility validation
   • Scalable production capacity

8. Nipro

   Headquarters: Japan

   Key Offering: Polymer‑glass hybrid containers for cell‑therapy applications.

   Nipro’s hybrid materials combine the strength of glass with the flexibility of polymers, meeting the demanding requirements of cell‑therapy products.

   Sustainability & Growth Initiatives:

   • Hybrid polymer‑glass solutions
   • Cell‑therapy focus
   • Rapid market entry
   • Sustainable material sourcing

9. Shandong Pharmaceutical Glass

   Headquarters: China

   Key Offering: High‑volume glass vial production for domestic biopharma.

   Shandong Pharmaceutical Glass has scaled its capacity to meet China’s growing biopharma sector, supported by government incentives that promote domestic manufacturing.

   Sustainability & Growth Initiatives:

   • Rapid capacity expansion
   • Domestic biopharma focus
   • Government incentives
   • Sustainable production practices

10. B Braun

    Headquarters: Germany

    Key Offering: Integrated infusion devices and aseptic packaging.

    B Braun’s infusion solutions combine device and packaging to streamline administration, enhancing patient safety and workflow efficiency.

    Sustainability & Growth Initiatives:

    • Integrated infusion device & packaging
    • Digital infusion monitoring
    • High‑volume infusion therapy focus
    • Patient‑centric safety commitment

Global Intravenous Injection Aseptic Packaging Market – Download Free Sample Report

Global Intravenous Injection Aseptic Packaging Market – Get Full Report

Market Outlook to 2034

Base year 2025 figures show the market at USD 9.45 billion. Estimated 2026 sales are projected at USD 10.02 billion, reflecting a steady rise in demand. By 2034, the market is expected to reach USD 16.28 billion, maintaining a CAGR of 7.1 % across the forecast horizon. The growth trajectory is supported by the continued expansion of biologics pipelines, increasing adoption of single‑use aseptic packaging, and tightening regulatory expectations around sterility assurance.

Future Trends Shaping the Market

• High‑barrier packaging materials that extend shelf life and reduce contamination risks.
• Smart packaging incorporating sensors, indicators, and IoT connectivity for real‑time integrity monitoring.
• Greater emphasis on recyclable and bio‑based polymers to align with circular economy goals.
• Digital traceability systems, including blockchain, to enhance supply‑chain transparency.
• Regulatory focus on audit‑ready validation and traceability to reduce product recalls.